Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

404 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transient detection of beta-galactosidase activity in hematopoietic cells, following reinjection of retrovirally marked autologous blood progenitors in patients with breast or ovarian cancer receiving high-dose chemotherapy.
Bagnis C, Chabannon C, Gravis G, Imbert AM, Maroc C, Bardin F, Ladaique P, Viret F, Genre D, Faucher C, Stoppa AM, Vey N, Blaise D, Maraninchi D, Viens P, Mannoni P. Bagnis C, et al. Among authors: vey n. Exp Hematol. 2002 Feb;30(2):108-15. doi: 10.1016/s0301-472x(01)00773-1. Exp Hematol. 2002. PMID: 11823045 Free article.
Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup.
Delaunay J, Vey N, Leblanc T, Fenaux P, Rigal-Huguet F, Witz F, Lamy T, Auvrignon A, Blaise D, Pigneux A, Mugneret F, Bastard C, Dastugue N, Van den Akker J, Fière D, Reiffers J, Castaigne S, Leverger G, Harousseau JL, Dombret H; French Acute Myeloid Leukemia Intergroup; Groupe Ouest-Est des Leucémies Aiguës Myéoblastiques; Leucémies Aiguës Myéoblastiques de l'Enfant; Acute Leukemia French Association; Bordeaux-Grenoble-Marseille-Toulouse cooperative groups. Delaunay J, et al. Among authors: vey n. Blood. 2003 Jul 15;102(2):462-9. doi: 10.1182/blood-2002-11-3527. Epub 2003 Mar 20. Blood. 2003. PMID: 12649129 Free article. Review.
Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen.
Mohty M, Bay JO, Faucher C, Choufi B, Bilger K, Tournilhac O, Vey N, Stoppa AM, Coso D, Chabannon C, Viens P, Maraninchi D, Blaise D. Mohty M, et al. Among authors: vey n. Blood. 2003 Jul 15;102(2):470-6. doi: 10.1182/blood-2002-12-3629. Epub 2003 Mar 20. Blood. 2003. PMID: 12649133 Free article.
Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimen.
Faucher C, Mohty M, Vey N, Gaugler B, Bilger K, Moziconnacci MJ, Stoppa AM, Coso D, Ladaique P, Chabannon C, Reviron D, Maraninchi D, Gastaut JA, Olive D, Blaise D. Faucher C, et al. Among authors: vey n. Exp Hematol. 2003 Oct;31(10):873-80. doi: 10.1016/s0301-472x(03)00194-2. Exp Hematol. 2003. PMID: 14550802 Free article.
The benefit of induction chemotherapy in patients age > or = 75 years.
Vey N, Coso D, Bardou VJ, Stoppa AM, Braud AC, Bouabdallah R, Sainty D, Mozziconacci MJ, Lafage M, Damaj G, Blaise D, Gastaut JA, Maraninchi D. Vey N, et al. Cancer. 2004 Jul 15;101(2):325-31. doi: 10.1002/cncr.20353. Cancer. 2004. PMID: 15241830 Free article.
CD8+ T cell dose affects development of acute graft-vs-host disease following reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
Mohty M, Bagattini S, Chabannon C, Faucher C, Bardou VJ, Bilger K, Vey N, Gaugler B, Stoppa AM, Coso D, Ladaique P, Olive D, Viens P, Blaise D. Mohty M, et al. Among authors: vey n. Exp Hematol. 2004 Nov;32(11):1097-102. doi: 10.1016/j.exphem.2004.07.020. Exp Hematol. 2004. PMID: 15539088 Free article. Clinical Trial.
404 results